Stay updated with breaking news from Vikram Karnani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THOUSAND OAKS, Calif., Feb. 19, 2024 /PRNewswire/ -- Amgen will host a webcasted call at 1:00 p.m. PT on Thursday, February 22, 2024 to discuss Rare Disease, its newly added fourth pillar of...
Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.
It's utilizing Horizon's drug development programs.
Horizon Therapeutics announced the Brazilian Health Regulatory Agency (ANVISA) has approved TEPEZZA as the first and only medicine approved in Brazil for treatment of thyroid eye disease.
-- First and only medicine approved in Brazil for the treatment of active TED, a serious, progressive, debilitating and potentially vision-threatening rare autoimmune disease --